Dow Pharm Drug Patent Portfolio
Dow Pharm owns 2 orange book drugs protected by 4 US patents Given below is the list of Dow Pharm's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10653656 | Topical pharmaceutical compositions for treating skin conditions | 22 Aug, 2038 | Active |
| US11324710 | Topical pharmaceutical compositions for treating skin conditions | 22 Aug, 2038 | Active |
| US6517847 | Topical gel delivery system | 03 Aug, 2020 | Expired |
| US5670547 | Moisturizing vehicle for topical application of vitamin A acid | 23 Sep, 2014 | Expired |
Latest Legal Activities on Dow Pharm's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Dow Pharm.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 19 Oct, 2023 | US10653656 |
|
Recordation of Patent Grant Mailed
Critical
| 10 May, 2022 | US11324710 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 10 May, 2022 | US11324710 |
|
Email Notification
Critical
| 21 Apr, 2022 | US11324710 |
|
Issue Notification Mailed
Critical
| 20 Apr, 2022 | US11324710 |
|
Application Is Considered Ready for Issue
Critical
| 06 Apr, 2022 | US11324710 |
| Dispatch to FDC | 06 Apr, 2022 | US11324710 |
|
Issue Fee Payment Received
Critical
| 05 Apr, 2022 | US11324710 |
|
Issue Fee Payment Verified
Critical
| 05 Apr, 2022 | US11324710 |
| Mailing Corrected Notice of Allowability | 22 Mar, 2022 | US11324710 |
|
Email Notification
Critical
| 22 Mar, 2022 | US11324710 |
|
Information Disclosure Statement considered
Critical
| 15 Mar, 2022 | US11324710 |
| Corrected Notice of Allowability | 15 Mar, 2022 | US11324710 |
|
Pubs Case Remand to TC
Critical
| 14 Mar, 2022 | US11324710 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 11 Mar, 2022 | US11324710 |
Dow Pharm's Family Patents
Dow Pharm Drug List
Given below is the complete list of Dow Pharm's drugs and the patents protecting them.
1. Altreno
Altreno is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10653656 | Topical pharmaceutical compositions for treating skin conditions |
22 Aug, 2038
(13 years from now)
| Active |
| US11324710 | Topical pharmaceutical compositions for treating skin conditions |
22 Aug, 2038
(13 years from now)
| Active |
| US6517847 | Topical gel delivery system |
03 Aug, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Altreno's drug page
2. Atralin
Atralin is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5670547 | Moisturizing vehicle for topical application of vitamin A acid |
23 Sep, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atralin's drug page